INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Results

21,251 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
Sylebra Capital LlcSee Footnote
PIIMPINJ INC
Open-market sale
SELL$221K
1,373 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

Page 478 of 532
← PrevNext →
16
BV
Bulho Matheus De A G VieraSVP Software and Control
ROKROCKWELL AUTOMATION, INC
Open-market sale · 10b5-1 plan
SELL
$8,877
22 sh
Dec 5, 2025
Dec 5, 2025
traded Dec 5, 2025
+0d
SEC Form 4

Evidence

16
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$69K
1,900 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

16
VS
Voskanian ShauntChief Revenue Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$92K
2,560 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

16
MS
Munshi SanjayChief Operating Officer
NTCTNETSCOUT SYSTEMS INC
Open-market sale · 10b5-1 plan
SELL$54K
2,000 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

16
HJ
Hennessy Daniel JDirector
INVInnventure, Inc.
Open-market sale · 10b5-1 plan
SELL$290K
55.8K sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

16
BV
Bulho Matheus De A G VieraSVP Software and Control
ROKROCKWELL AUTOMATION, INC
Open-market sale · 10b5-1 plan
SELL$38K
95 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

16
VS
Voskanian ShauntChief Revenue Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$139K
3,745 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

16
MB
Mulligan BrendanGeneral Counsel and Secretary
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$92K
2,492 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

16
DA
Dignan AndyPresident
FIVNFive9, Inc.
Open-market sale · 10b5-1 plan
SELL$14K
700 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

15
FR
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
TBPHTheravance Biopharma, Inc.
Open-market sale · 10b5-1 plan
SELL$291K
15.5K sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

15
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$74K
2,344 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

15
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$52K
1,673 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

15
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$42K
1,373 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

15
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$62K
1,989 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

14
CM
Campbell Lisa MDirector
DTDynatrace, Inc.
Open-market sale · 10b5-1 plan
SELL$11K
253 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

13
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$43K
1,200 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

13
HT
Herb TylerChief Accounting Officer
FIGFigma, Inc.
Open-market sale · 10b5-1 plan
SELL$41K
1,110 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

11
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$6,075
194 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

11
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$25K
824 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

11
TB
Ticho BarryCHIEF MEDICAL OFFICER
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$10K
323 sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

9
GC
Gibson ChristopherDirector, Chief Executive Officer
RXRXRECURSION PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$185K
40.0K sh
Dec 4, 2025Dec 5, 2025
traded Dec 4, 2025
+1dSEC Form 4

Evidence

8
AJ
Allan JonathanGENERAL COUNSEL & CORP SEC
STOKStoke Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$31K
1,004 sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

8
FR
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
TBPHTheravance Biopharma, Inc.
Open-market sale · 10b5-1 plan
SELL$146K
7,766 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

8
MJ
Manley Corey JEVP&CHIEF LEGAL/ADMIN OFFICER
OMCLOMNICELL, INC.
Open-market sale · 10b5-1 plan
SELL$244K
6,106 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

8
FR
Farnum RhondaSVP, COMM & MEDICAL AFFAIRS
TBPHTheravance Biopharma, Inc.
Open-market sale · 10b5-1 plan
SELL$146K
7,767 sh
Dec 3, 2025Dec 5, 2025
traded Dec 3, 2025
+2dSEC Form 4

Evidence

7
Dines DanielDirector, CEO and Chairman, 10% Owner
PATHUiPath, Inc.
Open-market sale · 10b5-1 plan
SELL$819K
45.0K sh
Dec 5, 2025Dec 5, 2025
traded Dec 5, 2025
+0dSEC Form 4

Evidence

7
BM
Barrett David MichaelDirector, Chief Executive Officer
EXFYExpensify, Inc.
Open-market sale · 10b5-1 plan
SELL$46K
30.0K sh
Dec 1, 2025Dec 5, 2025
traded Dec 1, 2025
+4dSEC Form 4

Evidence

48
SN
Sweeny NicoleChief Commercial Officer
KALVKalVista Pharmaceuticals, Inc.
Open-market sale
SELL$51K
3,813 sh
Nov 24, 2025Dec 4, 2025
traded Nov 24, 2025
+10dSEC Form 4

Evidence

45
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$194K
2,378 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

45
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$82K
994 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

45
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$65K
793 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

45
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$82K
994 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

45
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$194K
2,378 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

44
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$575K
7,335 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

44
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$487K
6,277 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

44
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$575K
7,335 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

44
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$487K
6,277 sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

43
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.37M
30.2K sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence

43
MB
McBee BranninChief Development Officer
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.00M
25.8K sh
Dec 2, 2025Dec 4, 2025
traded Dec 2, 2025
+2dSEC Form 4

Evidence